Table 2.
Donor screening tests for HIV, HCV, and HBV from 2000 to 2010
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV |
|
|
|
|
|
|
|
|
|
|
|
| anti-HIV (EIA) |
DA* |
DA |
DA |
GC† |
GC |
LG/GC‡ |
LG/GC |
LG/BioRad |
LG/BioRad |
LG |
LG |
| HIV-NAT |
|
|
|
|
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
|
| HCV |
|
|
|
|
|
|
|
|
|
|
|
| anti-HCV (EIA) |
LG/SI§ |
LG/SI |
LG/SI |
LG |
LG/DA |
SI/LG |
LG |
LG |
LG |
LG |
LG |
| HCV-NAT |
|
|
|
|
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
Roche/Chiron |
|
| HBV |
|
|
|
|
|
|
|
|
|
|
|
| HBsAg (EIA/CLIA) | DA/GC | DA/GC | DA/GC | GC/DA | GC | GC/LG | BioRad/SI | Abbott | Abbott | Abbott | Abbott |
*DA, Dong-A Pharm.
†GC, Green Cross co.
‡LG, LG Corp.
§SI, Samil co. LTD.